We also found that the autophagy/lysosome inhibitor chloroquine, but not proteasome inhibitor MG132 restored the protein levels of AGK in NASH mouse hepatocytes (Figure S1C), indicating that the reduction of AGK in NASH underwent a lysosome degradation dependent pathway. This evidence concerns the gene AGK and metabolic dysfunction-associated steatohepatitis.